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Background: The interactions established between macrophages and cancer cells are largely dependent on instructions
from the tumour microenvironment. Macrophages may differentiate into populations with distinct inflammatory profiles,
but knowledge on their role on cancer cell activities is still very scarce. In this work, we investigated the influence of
pro-inflammatory (LPS-stimulated) and anti-inflammatory (IL-10-stimulated) macrophages on gastric and colorectal cancer
cell invasion, motility/migration, angiogenesis and proteolysis, and the associated molecular mechanisms.
Methods: Following exposure of gastric and colon cancer cell lines to LPS- and IL-10-stimulated human macrophages,
either by indirect contact or conditioned media, we analyzed the effect of the different macrophage populations on
cancer cell invasion, migration, motility and phosphorylation status of EGFR and several interacting partners. Cancer-cell
induced angiogenesis upon the influence of conditioned media from both macrophage populations was assessed using
the chick embryo chorioallantoic membrane assay. MMP activities were evaluated by gelatin zymograhy.
Results: Our results show that IL-10-stimulated macrophages are more efficient in promoting in vitro cancer cell invasion
and migration. In addition, soluble factors produced by these macrophages enhanced in vivo cancer cell-induced
angiogenesis, as opposed to their LPS-stimulated counterparts. We further demonstrate that differences in the ability of
these macrophage populations to stimulate invasion or angiogenesis cannot be explained by the EGFR-mediated
signalling, since both LPS- and IL-10-stimulated macrophages similarly induce the phosphorylation of cancer cell EGFR,
c-Src, Akt, ERK1/2, and p38. Interestingly, both populations exert distinct proteolytic activities, being the IL-10-stimulated
macrophages the most efficient in inducing matrix metalloprotease (MMP)-2 and MMP-9 activities. Using a broad-spectrum
MMP inhibitor, we demonstrated that proteolysis was essential for macrophage-mediated cancer cell invasion and
angiogenesis.
Conclusions: We propose that IL-10- and LPS-stimulated macrophages distinctly modulate gastric and colorectal
cancer cell behaviour, as result of distinct proteolytic profiles that impact cell invasion and angiogenesis.
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Solid tumours are complex entities with several cellular
constituents other than malignant cells. Macrophages con-
stitute a major component of the immune infiltrate in these
tumours and are known to interact with cancer cells and to
play a crucial role in distinct steps of cancer progression,
such as survival, immune evasion, migration, invasion and
metastasis [1–4]. The presence of macrophages is usually
an indicator of poor prognosis in many types of malignan-
cies [2, 5]. In colorectal cancer, tumour-associated macro-
phages (TAMs) have been frequently correlated with better
prognosis [5, 6], although some studies refer that disease
outcome may vary according to macrophage molecular
profile and localization within the tumour [6–8]. In gastric
cancer, few reports point TAMs as positive predictors of
patient survival [9, 10], while most studies associate high
macrophage densities with tumour promotion and worse
overall survival [5, 11, 12]. Previous studies revealed that
macrophages stimulate breast cancer cell migration and
invasion through a paracrine loop involving colony-
stimulating factor-1 (CSF-1), produced by cancer cells, and
EGF produced by macrophages [1, 13]. Our own work re-
cently reinforced these studies, describing that gastric and
colorectal cancer cell motility, proteolysis and invasion are
stimulated by macrophages and that epidermal growth fac-
tor (EGF) is a key molecule in this crosstalk [14]. However,
nothing was described about the putative impact of differ-
ent macrophage subpopulations in gastric and colorectal
cancer cell properties and signalling.
Macrophages are highly plastic and very versatile in
response to microenvironment stimuli, including cues
released by neoplastic cells [15–17]. Despite their inter-
mediate activation state, macrophages are generally clas-
sified into two main functional phenotypes, reflecting
the Th1/Th2 response of CD4 T helper cells [18–20].
M1 macrophages are induced by interferon-gamma
(IFN-γ), microbial products, such as lipopolysaccharides
(LPS) and cytokines, like tumour necrosis factor-alpha
(TNF-α) [21]. They are generally characterized by in-
flammatory, microbicidal and tumoricidal activities, high
antigen presenting capacity, high secretion of IL-12, IL-
23, IL-6, nitric oxide (NO) and reactive oxygen interme-
diates (ROI) and low IL-10 production [22]. On the
other hand, M2 and M2-like macrophages polarize in re-
sponse to IL-4 and IL-13, IL-10 or glucocorticoid hor-
mones and are generally described to present low IL-12
and IL-6 and high IL-10 expression, as well as an in-
creased ability to scavenge, repair and remodel tissue,
promoting angiogenesis and tumour progression [22,
23]. Although most current studies suggest TAMs as be-
ing a skewed M2-like macrophage population, engaging
in cancer promoting activities, their phenotype can vary
according to their distribution within the tumour [19, 24–
26]. Therefore, clarifying the role of distinct macrophagesubsets in cancer and unravelling the concomitant mo-
lecular mechanisms will contribute to the identification of
novel therapeutic targets and biomarkers useful for patient
stratification.
In the present work, we studied LPS- and IL-10-
stimulated macrophages modulation of gastric and colo-
rectal cancer cell-related activities, such as invasion,
proteolysis, motility, migration and angiogenesis and
determined the associated molecular mechanisms.
Overall, our results demonstrate that distinct proteolytic
activities of these macrophage populations differently
modulate the behaviour of gastric and colorectal cancer
cells, providing new insights for the development of
new and more efficient anti-tumour therapies.Methods
Cell culture and reagents
AGS (CRL-1739) and RKO (CRL-2577) cells, derived
respectively from a human diffuse gastric and colon car-
cinoma, were purchased from the American Type Culture
Collection (ATCC, Manassas, VA, USA) in 2012. Cell lines
were tested and authenticated by autosomal STR DNA
profiling, in which a DNA sample was analysed with
POWERPLEX 16 HS kit (Promega, Madison, WI, USA).
The cell lines were last tested and authenticated on May
20th 2014, by a laboratory accredited by the College of
American Pathologists and with a Quality Management
System certified in accordance with NP EN ISO 9001:2008
(IPATIMUP Diagnostics, Porto, Portugal). Cells were
cultured at 37 °C and 5 % CO2 humidified-atmosphere in
RPMI1640 medium (Invitrogen, Merelbeke, Belgium), sup-
plemented with 10 % fetal bovine serum (FBS) (Lonza, Basel,
Switzerland), 100 U/ml penicillin and 100 μg/ml strepto-
mycin (Invitrogen).Human monocyte isolation and macrophage
differentiation
Human monocytes were isolated from healthy blood
donors as previously described [14]. For monocyte to
macrophage differentiation, 106 monocytes/ml/3,8cm2
were then cultured for 10 days in RPMI1640 medium,
supplemented with 10 % FBS and 100 U/ml penicillin
and 100 μg/ml streptomycin, in absence of M-CSF or
other exogenous factors. LPS- and IL-10-stimulated
macrophages were obtained by adding 10 ng/ml LPS
(Sigma-Aldrich) or IL-10 (ImmunoTools, Friesoythe,
Germany), respectively, for additional 72 h. Unstimulated
(naïve) macrophages were maintained with renewed
medium and used as control. All experimental protocols
were conducted following the approval and recommenda-
tions of the Ethics Comittee for Health from Centro Hos-
pitalar S. João (Porto – References 259/11 and 260/11).
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For cell surface receptor expression analysis, unstimulated,
LPS- and IL-10-stimulated macrophages were harvested, by
incubation with PBS-5 mM EDTA, for 30 min at 37 °C.
Macrophages were then resuspended in FACS buffer (PBS,
2 % FBS, 0.01 % sodium azide), and stained with anti-
human CD14-FITC, HLA-DR-PE (ImmunoTools) and
CD163-PE (R&D Systems, Minneapolis, MN, USA), for 30
min at 4 °C in the dark. Isotype-matched antibodies were
used as negative controls, to define background staining.
Cells were acquired on a FACSCalibur™ Flow Cytometer
(BD Biosciences), using Cell Quest Software (collecting 10
000 cells). Analysis was performed with FlowJo software.
Percentage of positive cells was calculated by subtracting
the respective isotype control. Experiments were performed
with cells from at least five different donors.
Enzyme-linked immunosorbent assay (ELISA)
TNF-α, IL-6 and IL-10 cytokines, present in conditioned
media (CM) from unstimulated, LPS- and IL-10-
stimulated macrophages, were quantified by ELISA ac-
cording to manufacturer’s instructions (BioLegend, San
Diego, CA, USA) [14].
Invasion assays
Invasion assays were performed as previously [14], using
BD BioCoat™ Matrigel™ Invasion Chambers (BD Biosci-
ences, Madrid, Spain) and AGS or RKO cells in the upper
compartment, and LPS- (LPSmac) or IL-10-stimulated
macrophages (IL-10mac) in the lower compartment. To
discard any influence of soluble factors released along
macrophage differentiation, media was renewed before in-
vasion assays. The broad MMP inhibitor Galardin (Calbio-
chem, Nottingham, UK) was used at a final concentration
of 10 μM. The invasive ratio was calculated as the ratio
between the number of invasive cells in the test condition
and the number of invasive cells in the control condition.
Conditioned media preparation
At the end of Matrigel™ invasion assays, CM of cancer
cells (CMMat(AGS)), LPS- (CMMat(LPSmac)) or IL-10-
stimulated (CMMat(IL-10mac)) macrophages or cancer
cells cultured in the presence of LPS- (CMMat(AGS +
LPSmac)) or IL-10-stimulated (CMMat(AGS + IL-10mac))
macrophages were collected. The influence of soluble
factors produced by LPS- (CM(LPSmac)) and IL-10-
stimulated (CM(IL-10mac)) macrophages, in the absence of
ECM components (without Matrigel™) were also prepared.
Immunocytochemistry
To evaluate macrophage morphology and cytoskeleton
organization, 19×104 monocytes/cm2 were seeded on
glass coverslips upon isolation, and left for 10 days in
culture. Treatments with LPS and IL-10 were performedas described above. To investigate the effect of distinct
macrophage populations on cancer cell motility and
EGFR phosphorylation, 2.7×104 AGS cells/cm2, seeded
on glass coverslips and maintained at 37 °C, 5 % CO2,
were treated or not with CM from LPS- (CM(LPSmac))
or IL-10-stimulated macrophages (CM(IL-10mac)) for 1
or 6 h. In parallel, RPMI media (RPMI) was used as
control. Cells were immunostained for phosphoEGFR
(Tyr1086), α-tubulin and F-actin and analysed as previ-
ously described [14].
Calculation of macrophage aspect ratio
Macrophage aspect ratio was quantified using ImageJ
software on images of actin/tubulin unstimulated, LPS-
or IL-10-stimulated macrophages. Aspect ratio was cal-
culated as the quotient between the length of each cell
major and minor axes, as previously described [27]. At
least 100 cells per donor/per condition were scored, and
at least three independent experiments were analysed
with cells from three different donors.
Quantification of motility-associated structures
Filopodia, lamellipodia and stress fibers were quantified
using ImageJ software on images of actin/tubulin regarding
AGS cells treated for 6 h with RPMI or CM from LPS- or
IL-10-stimulated macrophages. The percentage of cells with
these structures was calculated considering the total cell
number. At least 100 cells per donor/per condition were
scored, and at least three independent experiments were
analysed with cells from three different donors
Timelapse microscopy
To determine the effect of LPS- and IL-10-stimulated mac-
rophages on cancer cell migration, 5×104 AGS cells/cm2
were seeded. Immediately before each experiment, cells
were treated with CM from LPS- (CM(LPSmac)) or IL-10-
stimulated (CM(IL-10mac)) macrophages (1/3 total volume)
or equivalent RPMI medium (RPMI), as control. Cell trajec-
tories followed for 13 h were quantified as previously de-
scribed [14].
Gelatin zymography
MMP activity of LPS- and IL-10-stimulated macrophages,
and of co-cultures of AGS cells with both macrophage
populations was investigated by analysing CM from inva-
sion assays through gelatin zymography, as previously de-
scribed [14, 28].
Angiogenesis assay
Fertilized chicken (Gallus gallus) eggs obtained from
commercial sources (Pintobar, Braga, Portugal) were in-
cubated at 38 °C. At day 3 of incubation, a window was
opened in the shell, and 2–2.5 ml albumen was removed.
The window was sealed with adhesive tape, and the egg re-
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placed on the growing chorioallantoic membrane (CAM),
under sterile conditions. Then, 1×106 AGS cells in RPMI
medium and 1×106 AGS cells in CM from LPS-treated
(CM(LPSmac)) or IL-10-stimulated macrophages (CM(IL-
10mac)), with or without Galardin (30 μM), were incu-
bated within two separate rings. The window was resealed,
and 72 h after inoculation, rings were removed, and the
CAM was excised and photographed ex ovo under a
stereoscope (Olympus; SZX16 coupled DP71 camera).
The number of new vessels (<20 μm diameter) growing
radially towards the ring area was counted. At least 16
eggs were used for each condition. Means of ratios be-
tween vessel number in the test condition and vessel num-
ber in the control condition of each animal ± standard
error mean (SEM) were evaluated, and the statistical sig-
nificance of the differences was determined using the Stu-
dent’s t test (for samples with unequal variance).
Western blot
AGS or RKO cells, at approximately 80 % confluency,
were serum-starved overnight and treated with CM from
unstimulated (CM(mac)), LPS- (CM(LPS-mac)), IL-10-
stimulated macrophages (CM(IL-10mac)) or RPMI
as control (CMRPMI) for 1 h. Cell lysates, electrophoresis
and immunoblotting were performed as previously
described [14]. Primary antibodies used included
rabbit polyclonal antibodies against phospho-EGFR
(Y1086) (Zymed-Invitrogen), phospho-Src(Y416), phospho-
ERK1/2(T202/Y204), phospho-p38(Thr180/Tyr182), phos-
pho-Akt(S473), Akt, ERK1/2, Src, p38 (Cell Signaling, MA,
USA), α-tubulin (Sigma-Aldrich) or mouse monoclonal
antibody against EGFR (Transduction). Donkey anti-
rabbit or sheep anti-mouse-HRP-conjugated secondary
antibodies (GE Healthcare) were used, followed by ECL-
Detection (GE Healthcare).
siRNA transfection
siRNA targeting EGFR, previously validated for knockdown
efficiency in AGS, was purchased from Invitrogen. Prior to
transfection, AGS cells at 60 % confluence were incubated
in serum–antibiotic-free RPMI1640. Cells were transiently
transfected (75 nM EGFR siRNA) using Lipofectamine2000
transfection reagent (Invitrogen). As negative control, cells
transfected with Lipofectamine2000 were used. Eight hours
after transfection, medium was replaced by RPMI1640 sup-
plemented with 10 % FBS. Knockdown efficiency was tested
by western blot, 48 h after transfection.
Statistical analysis
Data were analysed using GraphPad Prism v.5 software, and
expressed as mean values of at least three independent ex-
periments and ± Standard Deviations (SD) or Standard Error
Mean (SEM), as indicated. Differences were tested withMann-Whitney test or Student’s t test for non-parametric
data, and were considered significant at a p value of less
than 0.05. Experiments were performed with at least three
different blood donors, as indicated.
Results
LPS- and IL-10-stimulated macrophages present distinct
phenotypes
To study the role of distinct macrophage populations on
the modulation of cancer cell-related activities, primary
human monocytes were first differentiated into macro-
phages, and left unstimulated or stimulated with 10 ng/ml
of LPS (LPS-stimulated) or IL-10 (IL-10-stimulated),
respectively. Macrophage polarization into distinct popu-
lations was confirmed by morphology, actin-tubulin cyto-
skeleton organization, cell surface receptors and cytokine
secretion analysis. F-actin and α-tubulin staining evi-
denced differences in cytoskeleton organization between
LPS- and IL-10-stimulated macrophages (Fig. 1a). LPS-
stimulated macrophages were elongated, presenting a sig-
nificantly higher cell aspect ratio (quotient between cell
major and minor axes length) (4.02 ± 0.03) (Fig. 1b), in
comparison with IL-10-stimulated (1.70 ± 0.23) or with
unstimulated macrophages (2.32 ± 0.54). Unstimulated
macrophages constituted a more morphologically hetero-
geneous population than those stimulated with LPS,
which contained areas of pronounced actin staining along
the cell body (Fig. 1a, arrows), or those stimulated with
IL-10, which contained podosome-like actin protrusions
displayed along the entire cell periphery (Fig 1a and b).
The macrophage cytokine profile, performed by ELISA,
revealed that LPS-stimulated macrophages produced sig-
nificantly higher levels of IL-6 and TNF-α, in comparison
with IL-10-stimulated ones, which in turn, secreted sig-
nificantly higher IL-10 and lower IL-6 and TNF-α levels
(Fig. 1c). Flow cytometry analysis of macrophage surface
receptors revealed that CD14, a macrophage lineage
marker, was not statistically differently expressed between
all macrophage populations (Fig. 1d, left panel). As ex-
pected, LPS-stimulated macrophages presented signifi-
cantly higher expression of the M1-like marker HLA-DR
and lower of the M2-like marker CD163 (Fig. 1d, middle
panel), in contrast to IL-10-stimulated macrophages,
which exhibited significantly lower expression of HLA-DR
and higher of CD163 (Fig. 1d, right panel).
Our results are in accordance with those previously de-
scribed in the literature concerning cytokine and cell sur-
face receptor expression profiles of M1- and M2-like
macrophages [29–31].
IL-10-stimulated macrophages are more efficient in
stimulating gastric and colorectal cancer cell invasion
To evaluate the influence of distinct macrophage popu-
lations on gastric and colorectal cancer cell invasion,
Fig. 1 Phenotypic characterization of LPS- and IL-10-stimulated macrophages derived from human CD14+ peripheral blood monocytes. a Representative
images of actin and tubulin stainings of LPS- and IL-10-stimulated macrophages polarized in absence of other external stimuli (mac) or in the presence of
10ng/ml LPS (LPSmac) or IL-10 (IL-10mac), respectively. F-actin was stained with Phalloidin-FITC (green), α–tubulin with a specific monoclonal antibody
followed by incubation with AlexaFluor594 secondary antibody (red) and nuclei were counterstained with DAPI (blue). Scale bars represent 50 μm. b
Morphological differences between macrophage populations were quantified by calculating the cell aspect ratio (quotient between cell major and minor
axes) of actin/tubulin stained cells. Chart reflects measurements of at least 100 cells per donor from, at least, 3 distinct donors. Bars represent mean values and
flags indicate standard deviations. c Cytokine production profile of LPS- and IL-10-stimulated macrophages. Cytokine concentration was measured by ELISA in
conditioned media from distinct macrophage populations. Charts indicate fold increase in IL-6, IL-10 and TNF-α expression, in comparison to unstimulated
macrophages. Data is representative of the cytokine profile of cells derived from at least 7 different donors. Bars represent mean values and flags indicate
standard deviations. d Expression of typical macrophage lineage (CD14) and polarization markers (HLA-DR and CD163) was determined by flow cytometry
of unstimulated, LPS- and IL-10-stimulated macrophages. Scatter charts represent percentage of positive cells for each cell surface marker considering data
obtained with cells derived from 5 different donors. *, significantly different at p< 0.05. IL-10, interleukin-10; LPS, lipopolysaccharide
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invasive gastric (AGS) or colorectal cancer (RKO) cells with
human macrophages, polarized towards an M1 or an M2-
like phenotype (Fig. 2a and b). Interestingly, the presence of
IL-10-stimulated macrophages significantly increased AGS
invasion through Matrigel-coated filters, relatively to AGS
cells alone and to LPS-stimulated macrophages. The latter
were still effective in inducing AGS cell invasion (fold of in-
crease 4.41 ± 0.56), although to a significantly lower extent
than IL-10-stimulated macrophages (14.11 ± 1.89) (Fig. 2a).The observed stimulation of invasion seems to occur by the
action of one or more soluble factors since, in this experi-
mental system, the two cell types do not contact directly.
Similarly, IL-10-stimulated macrophages induced RKO in-
vasion (fold of increase 2.935 ± 0.20) in a higher extent than
LPS-stimulated macrophages (1.203 ± 0.24) (Fig. 2b). As
controls, 10 ng/ml LPS or 10 ng/ml IL-10 alone were added
to invasion assays in the absence of macrophages, having
no influence on the number of invasive cancer cells (data
not shown).
Fig. 2 IL-10-stimulated macrophages are more efficient in stimulating cancer cell invasion. a AGS human gastric or b RKO human colorectal cancer cells
were incubated in BD BioCoatTM MatrigelTM Invasion Chambers for 24 h with RPMI medium (-), or human macrophages differentiated for 10 days and
stimulated for 72 h with 10 ng/ml LPS (LPSmac) or 10 ng/ml IL-10 (IL-10mac). Invasive cells and invasive ratio were determined as described in Materials
and Methods. Bars represent mean values of independent experiments performed with, at least, 4 different donors; flags indicate standard deviations
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stimulated macrophages affect gastric and colorectal
cancer cell invasion in different extents, being the IL-10-
stimulated more efficient. Since AGS cells were more
susceptible to macrophage-mediated invasion than RKO,
as indicated by the invasive ratios obtained, these cells
were selected for subsequent studies.
IL-10-stimulated macrophages are more efficient in
inducing cancer cell motility and migration
To investigate the effect of IL-10- and LPS-stimulated
macrophages on cancer cell motility and cytoskeleton
organization, F-actin and α-tubulin stainings were con-
ducted on AGS cells, after 6 h-treatments with CM
from both macrophage populations or with control
RPMI medium. In response to soluble factors produced
by both IL-10- and LPS-stimulated macrophages,
motility-associated structures, such as filopodia and la-
mellipodia, were observed (Fig. 3a, arrows). These
actin-rich structures, essentially filopodia, were more
frequent on cells exposed to CM from IL-10-stimulated
(CM(IL-10mac)) (38.7 ± 5.2 %), than on cells exposed to
CM from LPS-stimulated macrophages (CM(LPSmac))
(17.3 ± 2.5 %) or to control RPMI (9.9 ± 1.7 %) (Fig. 3b).
In addition, cells exposed to CM from IL-10-stimulated
macrophages had a more elongated shape, than cells ex-
posed to RPMI only (AGS + RPMI). The latter presented
a pronounced polyhedral shape and a strong cortical
actin staining at the periphery (Fig. 3a). Aiming to study
the effect of both macrophage populations on cancer
cell migration, high-resolution timelapse microscopy
was performed for 13 h. In the presence of CM from IL-
10-stimulated macrophages, cancer cells described
wider trajectories (Fig. 3c) and travelled significantly
longer distances (Fig. 3d) in comparison to cancer cells
stimulated with CM from LPS-stimulated macrophages
(CM(LPSmac)). Overall these results indicate that IL-
10-stimulated macrophages are more efficient thanLPS-sitmulated macrophages in inducing cancer cell
migration.
IL-10-stimulated macrophages promote cancer cell
mediated-angiogenesis
Angiogenesis is known to be crucial in several steps of
tumour progression and M2-like macrophages are de-
scribed to have pro-angiogenic potential [32]. To explore
the influence on new vessels formation of IL-10- and LPS-
stimulated macrophages, we incubated AGS cells with
CM from both populations (AGS + CM(LPSmac) and
AGS +CM(IL-10mac), respectively) in the chick embryo
chorioallantoic membrane (Fig. 4a). As internal control,
AGS cells with RPMI medium (AGS + RPMI) were in-
cluded in each egg. Our results show that inoculation of
AGS cells with CM from IL-10-stimulated macrophages
resulted in a significantly higher number of new vessels,
growing outwards the inoculation area (Fig. 4b, bottom
chart). This indicates that soluble factors produced by this
specific macrophage population are stimulating cancer
cell-mediated angiogenesis. Conversely, CM from LPS-
stimulated macrophages decreased the angiogenic response,
since the number of new vessels formed was lower than in
the control (Fig. 4b, upper chart). Altogether, our results
suggest that molecules produced by IL-10-stimulated mac-
rophages switch the balance of pro- and anti-angiogenic
molecules towards the stimulation of angiogenesis, while
unstimulated and LPS-stimulated macrophages have the op-
posite effect.
Cancer cell invasion requires activation of EGFR signalling
in the presence of IL-10- and LPS-stimulated
macrophages
EGFR and its associated signalling molecules have been
previously implicated in macrophage-derived stimuli of
invasion. In fact, silencing cancer cell EGFR expression
or immunodepletion of EGF from macrophage CM, led
to inhibition of motility, and abrogation of cancer cell
Fig. 3 IL-10-stimulated macrophages are more efficient in stimulating cancer cell motility and migration. a Representative images of actin and tubulin
stainings of AGS cells incubated, during 6 h, with RPMI (AGS + RPMI), LPS- (AGS +CM(LPSmac)) or IL-10-stimulated macrophage conditioned medium
(AGS+CM(IL-10mac)). F-actin was stained with Phalloidin-FITC (green), α-tubulin with a specific monoclonal antibody following incubation with an
AlexaFluor594 secondary antibody (red) while nuclei were counterstained with DAPI (blue). Scale bar represents 10 μm. b Quantification of motility-associated
actin/tubulin structures on AGS cells treated for 6 h with RPMI (-) or CM from LPS- (+CM(LPSmac)) and IL-10- (+CM(IL-10mac)) stimulated macrophages. %
of cells with filopodia, lamellipodia or stress fibers was calculated relatively to total cell number on images of F-actin/α-tubulin staining. Bars represent mean
values obtained with at least 100 cells in independent experiments with CM of macrophages obained from at least 3 different blood donors; flags indicate
standard error mean. *, significantly different at p< 0.05. c Representative images of AGS cell trajectories followed for 13 h, using timelapse microscopy.
Cells were incubated in the presence of RPMI (AGS + RPMI) or CM from LPS- (AGS +CM(LPSmac)) or IL-10-stimulated macrophages (AGS+CM(IL-10mac)).
Trajectories are represented as white lines traced between initial, intermediate and final xy positions. Scale bar represents 50 μm. d Distance (μm) travelled
by AGS cells in the presence of RPMI (AGS) or CM from LPS- (CM(LPSmac)) or IL-10-stimulated macrophages (CM(IL-10mac)) was quantified using the LSMib
Zeiss software (Carl Zeiss, Aalen, Germany) and bars represent mean values of distance migrated. A minimum of 100 cell trajectories were measured in
independent experiments, with CM from macrophages of at least 5 different donors; flags indicate standard deviations. *, significantly different from AGS
or RKO in RPMI medium at p< 0.05; **, significantly different at p<0.05
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Fig. 4 IL-10-stimulated macrophages promote cancer cell angiogenic response in the chick embryo chorioallantoic membrane (CAM) assay.
a Representative images of the CAM showing AGS cell inoculation area (ring delimited). A control with AGS and RPMI (AGS + RPMI) was always
included in each egg (20 X magnification), next to the inoculation site of AGS with CM from LPS- (AGS + CM(LPSmac)) or IL-10-stimulated
(AGS + CM(IL-10mac)) macrophages. b Quantification of the number of new blood vessels grown towards each inoculation area (only vessels
<20 μm diameter were counted). This quantification is compared with the control condition (AGS + RPMI) present at each egg (ratio between
the vessel number in the test condition and the vessel number in the control condition). Bars represent mean values obtained with 18 eggs
for AGS + CM(LPSmac), and 16 eggs for AGS + CM(IL-10mac) and flags indicate standard error mean *, significantly different at p <0.05
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sary for IL-10- and LPS-stimulated macrophage-mediated
invasion, AGS cells transiently silenced with siRNA for this
receptor were confronted with both macrophage popula-
tions on Matrigel invasion assays. Since silencing of EGFR
reached its maximum 48 h post-transfection (Fig. 5a), inva-
sion assays were performed 24 h after transfection. A sig-
nificant decrease in the invasion ability of cancer cells
confronted with IL-10-stimulated macrophages was ob-
served upon EGFR silencing, even when comparing with
AGS cells transfected with Lipofectamine only. The same
inhibitory effect was observed for LPS-stimulated macro-
phages, although not significantly, probably due to the
lower levels of invasion already induced by this macrophage
population (Fig. 5a).
Taking into account that EGFR is required for IL-10- and
LPS-stimulated macrophage-mediated invasion, we evalu-
ated if both macrophage populations differently affected
cancer cell EGFR signalling. Interestingly, no differences in
terms of EGFR tyrosine phosphorylation were found among
AGS cells treated with CM from these distinct macrophage
populations (Fig. 5b). Comparable patterns of intense
membrane phosphoEGFR immunostaining were observed,
whereas in the control condition (AGS+RPMI), the levels
of phosphorylation were low and scattered throughout the
cytoplasm. To evaluate the effect of distinct macrophage
populations on the activation of EGFR signalling partners,
lysates of AGS or RKO cells, previously incubated or not
with CM from unstimulated (CMmac), LPS- (CM(LPSmac))and IL-10-stimulated macrophages (CM(IL-10mac)), were
analysed by immunoblotting. Our results indicate that,
after 1 h, the three macrophage populations induce similar
increases in the phosphorylation of EGFR (Υ1086), c-Src
(Υ416), ERK1/2 (T202/Υ204), AKT (S473) and p38 (T180/
T182) (Fig. 5c, left panel) in AGS cells. Since no differences
in activation were observed in gastric cancer cells, similar
studies were conducted with colorectal cancer cells. Simi-
lar results were obtained in terms of RKO cells phosphor-
ylation of EGFR (Υ1086), c-Src (Υ416) and AKT (S473),
upon treatments with CM from unstimulated, LPS- and
IL-10-stimulated macrophages (Fig. 5c, right panel).
Altogether, these results point EGFR signalling as funda-
mental for the induction of invasion provided by IL-10-
and by LPS-stimulated-macrophages, as silencing EGFR
in AGS cells caused them to be unresponsive to stimula-
tion of invasion from both macrophage subsets. This
effect is more prominent in terms of IL-10-treated macro-
phages stimulation because LPS-treated macrophages
already cause lower levels of AGS invasion even with intact
EGFR expression. These observations led us to the conclu-
sion that other factors might be responsible for the distinct
pro-invasive ability of both macrophage populations.
Macrophage-mediated invasion and angiogenesis are
dependent on MMP activity
Proteolysis is a critical event in the progression of cancer
[33–35] and we previously reported that macrophages
are the major contributors to the enhanced proteolysis
Fig. 5 (See legend on next page.)
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Fig. 5 EGFR is required for both LPS- and IL-10-stimulated macrophage-mediated gastric cancer cell invasion. a EGFR expression was transiently silenced by
transfection with validated siRNA, at 48 h post-transfection. b Invasion assays with AGS cells (AGS), AGS cells with Lipofetamine2000 (AGS + Lipofect) or with
Lipofectamine2000 transfected together with siRNA directed to EGFR (AGS + siRNA EGFR) were performed in the presence or absence of LPS- (LPSmac) or
IL-10-stimulated (IL-10mac) macrophages. These assays were conducted at 24 h post-transfection and stopped at 48 h post-transfection, when maximum
inhibition was achieved. Bars represent mean values of independent experiments performed with macrophages from at least 4 different donors and flags
indicate standard error mean * significantly different from AGS at p< 0.05; ** significantly different at p< 0.05. c Tyrosine phosphorylation status of EGFR
residue Y1086 (red) after 1 h of incubation of AGS cells with RPMI (CM RPMI) or CM from unstimulated (CMmac), LPS- (CM(LPSmac)) or IL-10-stimulated
(CM(IL-10mac)) macrophages. Nuclei were counterstained with DAPI (blue). Scale bar represents 10 μm. The image is representative of independent
experiments performed with CM of macrophages, from at least three different donors. d AGS or RKO cells were treated or not (RPMI), during 1 h, with CM
from unstimulated (CMmac), LPS- (CM(LPSmac)) or IL-10-stimulated (CM(IL-10)mac) macrophages. Cell lysates were immunoblotted for phosphorylated and
total EGFR (Y1086), c-Src (Y416), Akt (S473), ERK1/2 (T202/Y204), and p38 (Thr180/Tyr182). Immunoblots were analyzed by densitometry analysis in comparison with
corresponding α-tubulin and total protein expression levels. Images are representative of independent experiments performed with CM of macrophages from
at least 3 different donors
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showed that, besides EGFR, matrix metalloproteases
(MMP) were crucial for macrophage-mediated cancer cell
invasion, since the presence of a broad MMP inhibitor
(Galardin) was able to abolish this effect [14]. Thus,
invasion assays with AGS, in the presence or absence of
LPS- (CM(LPSmac)) or IL-10-stimulated (CM(IL-10mac))
macrophages, were carried out in the presence of Galardin
(Fig. 6a). In fact, by inhibiting MMPs, both LPS- and IL-
10-stimulated macrophage-mediated stimuli of invasion
were significantly reduced.
Since MMP activity is important in terms of angiogenesis
[36] and that CM from IL-10-stimulated macrophages in-
creased the angiogenic response in the chick embryo CAM
assay, we inoculated AGS cells with CM from IL-10-
stimulated macrophages with Galardin (AGS+CM(IL-10-
mac) +Galardin), using a control condition, in the same egg,
without the inhibitor (AGS +CM(IL-10-mac)) (Fig. 6b). The
presence of Galardin resulted in a slight, although statisti-
cally significant, decrease in the ability of IL-10-stimulated
macrophages to induce cancer cell-mediated angiogenesis.
These results indicate that MMPs are required to support
cancer cell invasion provided by both macrophage popula-
tions, and to the stimulation of angiogenesis induced by CM
derived from IL-10-stimulated macrophages.
IL-10-stimulated macrophages display enhanced MMP-2
and MMP-9 activities, particularly in the presence of
cancer cells
Considering the ability of a broad-MMP inhibitor to de-
crease cancer cell invasion and cancer cell-induced angio-
genesis, we hypothesized that the distinct ability of LPS- and
IL-10-stimulated macrophages in inducing these cancer cell
activities could be associated to proteolytic differences.
Therefore, gelatin zymography studies were conducted using
CM from both macrophage-populations, when cultured
alone or with cancer cells (Fig. 6c). Our results show that
IL-10-stimulated macrophages (CMMat(IL-10mac)) present
significantly higher pro- and active-MMP-9 activities than
LPS-stimulated macrophages (CMMat(LPSmac)) (Fig. 6d).Concerning AGS cells (CMMat(AGS)), levels of MMP-9
are similar to those of LPS-stimulated but significantly
lower from those of IL-10-stimulated macrophages.
Regarding the proteolytic activity of invasion assays super-
natants, pro- and active-MMP-9 levels in co-cultures of
AGS cells with LPS-stimulated macrophages (CMMa-
t(AGS + LPSmac) are comparable to individual population
levels. Nevertheless, pro- and active-MMP-9 proteolytic ac-
tivity is significantly higher in co-cultures of AGS with
IL-10(CMMat(AGS+IL-10mac)) than with LPS-stimulated
macrophages (CMMat(AGS + LPSmac)) (Fig. 6d). Regard-
ing MMP-2, both pro- and active forms were significantly
higher in IL-10- than in LPS-stimulated macrophages
(Fig. 6e). Considering co-cultures, pro- and active-MMP-2
activity was considerably higher in AGS cells with IL-10-
stimulated (CMMat(AGS + IL-10mac)) than in the corre-
sponding condition with LPS-stimulated macrophages
(CMMat(AGS + LPSmac)). In fact, no differences on
MMP-2 activity were observed between LPS-stimulated
macrophages alone and in co-cultures with AGS cells
(Fig. 6e), suggesting that this metalloprotease is mainly pro-
duced by macrophages.
Taken together, these results indicate that differences
in the stimuli of invasion provided by LPS- and IL-10-
stimulated macrophages are probably related with dis-
tinct proteolytic activity profiles. Besides similar abilities
in stimulating EGFR phosphorylation, IL-10-stimulated
macrophages provide, in fact, higher MMP-2 and MMP-
9 activities than their LPS-stimulated counterparts.
Discussion
In this study, we investigated the role of M1 versus M2-
like macrophages on gastric and colorectal cancer cell
functions. Our results demonstrate that: 1) macrophages
distinctly modulate cancer cell invasion, motility, proteoly-
sis and angiogenesis, being M2-like macrophages (IL-10-
stimulated) more efficient than their M1-like counterparts
(LPS-stimulated); 2) EGFR phosphorylation is essential for
both macrophage populations-mediated invasion; 3) des-
pite differences in their pro-invasive ability, LPS- and IL-
Fig. 6 (See legend on next page.)
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Fig. 6 MMP activity influences LPS- and IL-10-stimulated macrophage-mediated cancer cell invasion and angiogenesis. a AGS cells were incubated in BD
BioCoatTM MatrigelTM Invasion Chambers for 24 h with RPMI medium (-) or macrophages stimulated for 72 h with 10 ng/ml LPS (LPSmac)) or with 10 ng/ml
IL-10 (IL-10mac) and supplied or not with a pharmacological inhibitor of matrix metalloproteases, Galardin (10 μM). Invasive cells were determined as de-
scribed in Materials and Methods. Bars represent mean values of independent experiments performed with, at least, 4 different donors; flags indicate standard
deviations. *, significantly different from AGS in RPMI medium at p< 0.05; **, significantly different at p< 0.05. b Quantification of the number of new blood
vessels grown in the CAM towards each inoculation area (<20 μm diameter). A control with AGS and CM from IL-10-treated macrophages without Galardin
(AGS +CM(IL-10mac)) was always included in each egg next to the inoculation area of AGS and CM of IL-10-stimulated macrophages supplemented with
Galardin (30 μM) (AGS+CM(IL-10mac) + Galardin). Bars represent mean values (ratio between the vessel number in the test condition and the vessel number
in the control condition, per animal) obtained from a total of 35 eggs and CM of macrophages derived from 3 different donors. Flags indicate standard error
mean; *, significantly different at p <0.05. c Conditioned media from MatrigelTM invasion assays containing AGS (CMMat(AGS)), unstimulated (CMMat(mac)),
LPS- (CMMat(LPSmac)), IL-10-stimulated macrophages (CMMat(IL-10mac)), AGS and unstimulated (CMMat(mac)), LPS- (CMMat(AGS + LPSmac)) and IL-10-
stimulated macrophages (CMMat(AGS + IL-10mac)) were run on gelatin zymograms. Proteolytic activity bands were revealed in white on a blue background
stained with Coomassie. d and e Densitometry analysis using QuantityOne® software (BioRad) allowed quantification of pro-MMP-9 and MMP-9 (d) and
pro-MMP-2 and MMP-2 (e) activities. Proteolytic activity was expressed as percentage of the proteolytic activity of unstimulated macrophages. Data
correspond to mean values of independent experiments performed with macrophages derived from at least 5 different blood donors. Flags indicate
standard error mean; *, significantly different from AGS at p<0.05; **, significantly different at p< 0.05
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EGFR, c-Src, ERK1/2, Akt and p38 phosphorylation; 4)
most importantly, MMPs are crucial for macrophage-
mediated invasion and angiogenesis and discrepancies in
the strength of these stimuli seems related with differences
in the MMP activity profile of each macrophage popula-
tion. As such, the higher proteolytic activity of IL-10-
stimulated macrophages parallels with their higher ability
to stimulate cancer cell invasion and angiogenesis.
Due to their pro-inflammatory phenotype, M1 macro-
phages are often associated with tumour-suppressor and
cytotoxic activities. In contrast, M2-like macrophages, which
display an anti-inflammatory phenotype, are generally en-
gaged in tumour-promoting activities, in particular angio-
genesis and extracellular matrix remodelling [19]. These
macrophage populations also exhibit distinct molecular pro-
files, which are, to a certain extent, associated with the
microenvironment to where monocytes are recruited and
differentiated [4]. In our system, these two distinct macro-
phage phenotypes were obtained upon exogenous stimula-
tion of primary human monocytes, and exhibited previously
described characteristics of extremes in an activation
spectrum [22]. M2-like macrophages, which share charac-
teristics of tumour-associated macrophages (TAMs) [19],
were indeed more efficient in stimulating gastric and colo-
rectal cancer cell invasion than their LPS-stimulated coun-
terparts. This finding is in agreement with the ability of M2-
like macrophages to stimulate cancer cell migration, inva-
sion and metastasis in other types of tumours [1]. Interest-
ingly, LPS-stimulated macrophages also increased cancer
cell invasion, although to a less extent. Accordingly, Hage-
mann and collaborators have previously described that LPS-
stimulated macrophages were less efficient in promoting
breast cancer cell invasion than naïve macrophages [37].
Cancer cell invasion results from the balance between
migration and proteolysis, which facilitates the movement
of cells through extracellular matrix (ECM) degraded
components, allowing the release of pro-invasive and pro-motility factors entrapped within the matrix [33, 35, 38].
We have previously demonstrated that cancer cell motility is
another crucial invasion-related activity stimulated by naïve
macrophages [14]. In the present study, LPS- and IL-10-
stimulated macrophages induced cancer cell cytoskeleton
reorganization and the formation of motility-associated
structures, such as lamellipodia and filopodia. Nevertheless,
soluble molecules produced by IL-10-stimulated macro-
phages were significantly more efficient in inducing cancer
cell migration than those released by LPS-stimulated macro-
phages. A paracrine loop involving the production of EGF
by macrophages and CSF-1 by cancer cells has been demon-
strated [13]. Disruption of this cellular crosstalk by blockade
of EGF receptor or CSF-1 receptor signalling inhibited can-
cer cell migration and invasion [13]. We have also recently
described the relevance of EGF-like ligands, produced by
naïve macrophages, for the activation of gastric and colorec-
tal cancer cell. EGFR and its downstream partners such as
Akt, ERK1/2 and c-Src were proved to be crucial for stimu-
lation of invasion and motility [14]. Interestingly, in the
present work we demonstrate that these signalling pathways
are being similarly induced by LPS- and IL-10-stimulated
macrophages, despite their distinct effects on cancer cell in-
vasion and motility. In fact, soluble factors released by both
macrophage populations induced similarly EGFR, c-Src,
ERK1/2, Akt, and p38 phosphorylation. Thus, our results in-
dicate that, although critical, this pathway is not responsible
for the differences in invasion-related cellular activities pro-
moted by LPS- and IL-10-stimulated macrophages, pointing
to a distinct mechanism.
MMPs are essential for tumour cell invasion through
the basement membrane [35, 38] and increased expression
has been positively correlated with tumour progression
[36, 39]. Host cells, especially macrophages, are consid-
ered the main source of these enzymes at the tumour
microenvironment [40] and we and others have recently
reported that macrophage-mediated cancer cell invasion
and migration are sensitive to MMP inhibition [14, 37]. In
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IL-10-stimulated macrophages seems to be associated with
the enhancement of gastric cancer cell invasion. As previ-
ously, proteolytic activity inhibition impaired macrophage-
mediated invasion [14, 37]. Taken together, our results sug-
gest that M2-like macrophages are more efficient than their
M1 counterparts in stimulating gastric cancer cell invasion,
likely due to their increased MMP-2 and MMP-9 activity
and higher ability to promote cancer cell migration. With
increased capacity to degrade ECM components and en-
hanced motility and migration, the invasive ability of gastric
cancer cells might be then supported.
Tumour-induced angiogenesis is essential for tumour
progression since it is important for local tumour growth,
survival, escape from the primary site and establishment
of metastasis [41]. Macrophages are described as pro-
ducers of pro-angiogenic cytokines and growth factors
[42] and have already been associated with tumours neo-
vascularization [43–45]. Nevertheless, different angiogenic
potentials have been associated with distinct macrophage
populations, with M2-like macrophages presenting pro-
angiogenic features [46, 47]. Consistent with this, we ob-
served stimulation of gastric cancer cell-induced angio-
genesis in vivo by soluble factors secreted by M2-like
macrophages. Since MMPs are crucial regulators at dis-
tinct steps of the angiogenic process [36, 48], we propose
that the angiogenic stimulatory effect of M2 macrophages
could be related to their enhanced MMP-2 and MMP-9
activities. However, we cannot exclude that other pro-
angiogenic factors, secreted by this macrophage popula-
tion might also be involved. M1 macrophages, on the
other hand, were previously reported to inhibit angiogen-
esis in mice, even in the presence of increased levels of
vascular endothelial growth factor (VEGF) [47].Conclusions
Overall, our results provide valuable insights into the
interplay between cancer cells and two distinctly polarized
macrophage populations, frequently found at the tumour
microenvironment. By examining the molecular mecha-
nisms and highlighting the importance of MMPs in such
cellular crosstalk, this work offers new considerations to
the establishment of more efficient therapeutic strategies,
aiming to impair cancer invasion and progression.
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